Likely active: portfolio news Jul 2026 Verified 5 Nov 2026
Aisling Capital
Healthcare investment firm backing pharmaceutical, biotech, medical device and healthcare services companies, with $1.8 billion in assets. Based in New York, NY.
- Type
- VC firm
- Location
- New York, New York, United States
- Stages
- Seed
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences, Food, Medtech
- Fund size / AUM
- $63.6M gross private fund assets (Form ADV; private funds: 2, of which venture capital: 2)
- Portfolio mix
- Biotech and pharma 92%; Medtech and digital health 8% (n=30, 2017 to 2025)
- Website
- aislingcapital.com
Contacts on file
For Aisling Capital, the paid file holds: 8 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
QuintilesLoxoBiohavenHarmonyZELTIQ
Sources
- adviserinfo.sec.gov/firm/summary/157698
- www.aislingcapital.com/
- www.aislingcapital.com/portfolio
- www.aislingcapital.com/team
- www.aislingcapital.com/about
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 24 lists
Biotech investors in New York (29)Seed food and beverage investors in the US (47)Medtech investors in New York (53)Food and beverage venture capital firms in the US (91)Healthtech investors in New York (100)Seed food and beverage investors (106)Seed investors in New York (128)Seed biotech investors in the US (159)Food and beverage investors (179)Seed medtech investors in the US (205)Seed medtech investors (278)Biotech venture capital firms in the US (297)Seed biotech investors (300)Medtech venture capital firms in the US (350)Seed healthtech investors in the US (437)Venture capital firms in New York (440)Medtech investors (457)Biotech investors (484)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Seed investors in the US (1,043)Healthtech investors (1,207)Seed investors (1,892)Venture capital firms in the US (2,975)